# FDA recall D-0664-2017

> **Medisca, Inc.** · Class II · drug recall initiated 2017-04-03.

## Product

ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-06), c) 5 grams (NDC 38779-0891-03), d) 25 grams (NDC 38779-0891-04),  and e) 100 grams (NDC 38779-0891-09)  Bottles,  Packed by MEDISCA INC. PLATTSBURGH, NY 12901; Product Code 0891

## Reason for recall

cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

## Distribution

Nationwide, Australia, Bahamas, Italy, Singapore, Thailand, United Kingdom

## Key facts

- **Recall number:** D-0664-2017
- **Recalling firm:** Medisca, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-04-03
- **Report date:** 2017-04-19
- **Termination date:** 2019-06-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Plattsburgh, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0664-2017

## Citation

> AI Analytics. FDA recall D-0664-2017. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-0664-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*